CD8A and diabetes mellitus: The peptide from these fusobacteria activates pathogenic IGRP-specific CD8+T cells in NOD mice [95], accelerating diabetes in the NOD-mouse-derived NY8.3 CD8+ T cell receptor transgenic mouse, which expresses a large number of CD8+ T cells that react to the IGRP peptide.